Enanta Pharmaceuticals Overview
- Year Founded
-
1995
- Status
-
Public
- Employees
-
74
- Stock Symbol
-
ENTA
- Share Price
-
$7.62
- (As of Friday Closing)
Enanta Pharmaceuticals General Information
Description
Enanta Pharmaceuticals Inc is a biotechnology company that uses its robust, chemistry-driven approach and drug discovery capabilities to discover and develop small molecule drugs with an emphasis on viral infections and immunological diseases. The company has single operating segment.
Contact Information
Website
www.enanta.comCorporate Office
- 4 Kingsbury Avenue
- Watertown, MA 02472
- United States
Corporate Office
- 4 Kingsbury Avenue
- Watertown, MA 02472
- United States
Enanta Pharmaceuticals Stock Performance
As of 20-Nov-2026, Enanta Pharmaceuticals’s stock price is $7.62. Its current market cap is $222M with 29.2M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.62 | $7.98 | $7.56 - $17.15 | $222M | 29.2M | 289K | -$2.35 |
Enanta Pharmaceuticals Financials Summary
As of 30-Sep-2026, Enanta Pharmaceuticals has a trailing 12-month revenue of $63M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Sep-2026 | FY 2025 30-Sep-2025 | FY 2024 30-Sep-2024 |
|---|---|---|---|---|
| EV | 251,334 | 251,334 | 111,183 | 41,419 |
| Revenue | 63,001 | 63,001 | 65,324 | 67,635 |
| EBITDA | (57,577) | (57,577) | (80,724) | (119,282) |
| Net Income | (68,248) | (68,248) | (81,889) | (116,045) |
| Total Assets | 275,577 | 275,577 | 280,732 | 376,652 |
| Total Debt | 54,757 | 54,757 | 57,903 | 55,467 |
Enanta Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Enanta Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Enanta Pharmaceuticals Comparisons
Industry
Financing
Details
Enanta Pharmaceuticals Competitors (84)
One of Enanta Pharmaceuticals’s 84 competitors is Pliant Therapeutics, a Formerly VC-backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pliant Therapeutics | Formerly VC-backed | San Francisco, CA | ||||
| Vir Biotechnology | Formerly VC-backed | San Francisco, CA | ||||
| Ayala Pharmaceuticals | Corporation | Wilmington, DE | ||||
| Dynavax Technologies | Formerly VC-backed | Emeryville, CA | ||||
| Lisata Therapeutics | Corporation | Basking Ridge, NJ |
Enanta Pharmaceuticals Patents
Enanta Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026217507-A1 | Anti-inflammatory compounds | Pending | 08-Apr-2025 | ||
| WO-2026198843-A1 | Anti-inflammatory compounds | Pending | 21-Mar-2025 | ||
| WO-2026193124-A1 | Anti-inflammatory compounds | Pending | 13-Mar-2025 | ||
| WO-2026193125-A1 | Anti-inflammatory compounds | Pending | 13-Mar-2025 | ||
| WO-2026183251-A1 | Anti-inflammatory compounds | Pending | 27-Feb-2025 | C07D471/04 |
Enanta Pharmaceuticals Signals
Enanta Pharmaceuticals ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
35.23 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
Enanta Pharmaceuticals FAQs
-
When was Enanta Pharmaceuticals founded?
Enanta Pharmaceuticals was founded in 1995.
-
Where is Enanta Pharmaceuticals headquartered?
Enanta Pharmaceuticals is headquartered in Watertown, MA.
-
What is the size of Enanta Pharmaceuticals?
Enanta Pharmaceuticals has 74 total employees.
-
What industry is Enanta Pharmaceuticals in?
Enanta Pharmaceuticals’s primary industry is Biotechnology.
-
Is Enanta Pharmaceuticals a private or public company?
Enanta Pharmaceuticals is a Public company.
-
What is Enanta Pharmaceuticals’s stock symbol?
The ticker symbol for Enanta Pharmaceuticals is ENTA.
-
What is the current stock price of Enanta Pharmaceuticals?
As of 20-Nov-2026 the stock price of Enanta Pharmaceuticals is $7.62.
-
What is the current market cap of Enanta Pharmaceuticals?
The current market capitalization of Enanta Pharmaceuticals is $222M.
-
What is Enanta Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Enanta Pharmaceuticals is $63M.
-
Who are Enanta Pharmaceuticals’s competitors?
Pliant Therapeutics, Vir Biotechnology, Ayala Pharmaceuticals, Dynavax Technologies, and Lisata Therapeutics are some of the 84 competitors of Enanta Pharmaceuticals.
-
What is Enanta Pharmaceuticals’s annual earnings per share (EPS)?
Enanta Pharmaceuticals’s EPS for 12 months was -$2.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process